Literature DB >> 18270190

Perioperative renal failure: hypoperfusion during cardiopulmonary bypass?

Marco Ranucci1.   

Abstract

Acute renal failure is one of the most frequent and life-threatening complications after cardiac surgery. There is a recent growing deal of information suggesting that during the time of cardiopulmonary bypass kidneys may suffer from an imbalance between oxygen supply and oxygen needs. A low hematocrit during cardiopulmonary bypass is associated with an increase risk of acute renal failure, mainly due to a low oxygen delivery. An inadequate oxygen delivery during cardiopulmonary bypass is associated with lactate production, and under normothermic conditions, hyperlactatemia appears for an oxygen delivery below 260 mL min(-1) m(-2). The risk of acute renal failure significantly increases for an oxygen delivery approximately at the same value (272 mL min(-1) m(- 2)). During cardiopulmonary bypass, the pump flow should be coupled with the hematocrit to avoid falling below this critical oxygen delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18270190     DOI: 10.1177/1089253207311141

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


  11 in total

1.  Low Oxygen Delivery as a Predictor of Acute Kidney Injury during Cardiopulmonary Bypass.

Authors:  Richard F Newland; Robert A Baker
Journal:  J Extra Corpor Technol       Date:  2017-12

Review 2.  Cardiac surgery-associated acute kidney injury.

Authors:  Huijuan Mao; Nevin Katz; Wassawon Ariyanon; Lourdes Blanca-Martos; Zelal Adýbelli; Anna Giuliani; Tommaso Hinna Danesi; Jeong Chul Kim; Akash Nayak; Mauro Neri; Grazia Maria Virzi; Alessandra Brocca; Elisa Scalzotto; Loris Salvador; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

Review 3.  Novel biomarkers for cardiac surgery-associated acute kidney injury: a skeptical assessment of their role.

Authors:  David Sidebotham
Journal:  J Extra Corpor Technol       Date:  2012-12

Review 4.  Sex and the Risk of AKI Following Cardio-thoracic Surgery: A Meta-Analysis.

Authors:  Joel Neugarten; Sandipani Sandilya; Beenu Singh; Ladan Golestaneh
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-20       Impact factor: 8.237

Review 5.  Renal Hemodynamics, Function, and Oxygenation in Critically Ill Patients and after Major Surgery.

Authors:  Sven-Erik Ricksten; Gudrun Bragadottir; Lukas Lannemyr; Bengt Redfors; Jenny Skytte
Journal:  Kidney360       Date:  2021-03-03

6.  Goal Directed Perfusion Is Not Associated with a Decrease in Acute Kidney Injury in Patients Predicted to Be at High Risk for Acute Renal Failure after Cardiac Surgery.

Authors:  Mark Broadwin; Monica Palmeri; Tyler Kelting; Robert Groom; Michael Robich; F Lee Lucas; Robert Kramer
Journal:  J Extra Corpor Technol       Date:  2022-06

7.  Prognostic Significance of Serum NGAL and Troponin I against Acute Kidney Injury in Egyptian ICU Patients after Open Heart Surgery: A Pilot Study.

Authors:  Osama F Mosa
Journal:  Kidney Dis (Basel)       Date:  2018-07-04

8.  Outcome of Patients with Infective Endocarditis who were Treated with Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

Authors:  Santhosh G John; Preethi William; Sangeetha Murugapandian; Bijin Thajudeen
Journal:  Clin Pract       Date:  2014-10-30

9.  Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio; Elisabet Farrero; Casimiro Javierre; Josep L Ventura; Rafael Manez
Journal:  Crit Care       Date:  2013-12-13       Impact factor: 9.097

Review 10.  Acute Kidney Injury following Cardiopulmonary Bypass: A Challenging Picture.

Authors:  Dianxiao Liu; Baohui Liu; Zhenxing Liang; Zhi Yang; Fangjian Ma; Yang Yang; Wei Hu
Journal:  Oxid Med Cell Longev       Date:  2021-03-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.